MA52226A - Nouveaux analogues de glp-1 - Google Patents

Nouveaux analogues de glp-1

Info

Publication number
MA52226A
MA52226A MA052226A MA52226A MA52226A MA 52226 A MA52226 A MA 52226A MA 052226 A MA052226 A MA 052226A MA 52226 A MA52226 A MA 52226A MA 52226 A MA52226 A MA 52226A
Authority
MA
Morocco
Prior art keywords
glp
new analogues
analogues
new
Prior art date
Application number
MA052226A
Other languages
English (en)
Other versions
MA52226B1 (fr
Inventor
Vinod Sampatrao Burade
Nishith Chaturvedi
Dhiren Rameshchandra Joshi
Ravishankara Madavati Nagaraja
Muthukumaran Natarajan
Kunal Pandya
Brijeshkumar Patel
Vipulkumar Shankarbhai Patel
Pradeep Dinesh Shahi
Krunal Harishbhai Soni
Rajamannar Thennati
Abhishek Tiwari
Rishit Mansukhlal Zalawadia
Original Assignee
Sun Pharmaceutical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Ind Ltd filed Critical Sun Pharmaceutical Ind Ltd
Priority claimed from PCT/IB2019/052835 external-priority patent/WO2019193576A1/fr
Publication of MA52226A publication Critical patent/MA52226A/fr
Publication of MA52226B1 publication Critical patent/MA52226B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Physiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA52226A 2018-04-05 2019-04-05 Nouveaux analogues de glp-1 MA52226B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201821013109 2018-04-05
PCT/IB2019/052835 WO2019193576A1 (fr) 2018-04-05 2019-04-05 Nouveaux analogues de glp-1

Publications (2)

Publication Number Publication Date
MA52226A true MA52226A (fr) 2021-02-17
MA52226B1 MA52226B1 (fr) 2022-08-31

Family

ID=83280018

Family Applications (2)

Application Number Title Priority Date Filing Date
MA59093A MA59093B1 (fr) 2018-04-05 2019-04-05 Nouveaux analogues de glp-1
MA52226A MA52226B1 (fr) 2018-04-05 2019-04-05 Nouveaux analogues de glp-1

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MA59093A MA59093B1 (fr) 2018-04-05 2019-04-05 Nouveaux analogues de glp-1

Country Status (1)

Country Link
MA (2) MA59093B1 (fr)

Also Published As

Publication number Publication date
MA52226B1 (fr) 2022-08-31
MA59093B1 (fr) 2024-05-31

Similar Documents

Publication Publication Date Title
IL283385A (en) Modified gip peptide analogues
EP3870593A4 (fr) Analogues nucléotidiques
EP3857879A4 (fr) Simplification de prédiction inter-intra combinée
LT3774862T (lt) Nauji glp-1 analogai
MA46180A (fr) Analogues de l'amyline
IL289197A (en) 2-hydroxycycloalkane-1-carbamoyl derivatives
MA51004A (fr) Nouveaux analogues spirobicycliques
DK3490991T3 (da) Coelenterazine analogues
DK3746466T3 (da) Fremstilling af glucagonpeptider
EP3750579A4 (fr) Injecteur
EP3826702A4 (fr) Injecteur
IL285547A (en) Long-acting glp-2 analogs
EP4028409A4 (fr) Nouveaux peptides
EP3710462A4 (fr) Analogues de brartémicine
EP3890845C0 (fr) Structure d'escalade
IL279938A (en) Spirochromane derivatives
DK3512495T3 (da) Formuleringer af prostacyklinanaloger
EP3866932A4 (fr) Analogues de nucléosides de la 6-mercaptopurine
EP3911809A4 (fr) Section structurale
IL285119A (en) Use of spiropidion
EP3906225C0 (fr) Analogues de pantothénamide
EP3400237A4 (fr) Analogues peptidiques
EP3904039A4 (fr) Injecteur
MA52226A (fr) Nouveaux analogues de glp-1
EP3892371A4 (fr) Structure fonctionnelle